Br Hear_ 1995;73:587-588

VOLUME 73 * AUTHOR INDEX

Key: E = Editorial; F = Filler; L = Letter; C = Correction

Abrams S, 190Abrams SE, 177Accurso V, 258Adams JN, 87, 125, 265Adelman AG, 534Aggarwal RK, 392 (L), 571Agostini D, 69Ajayi AAL, 488 (L)Alday LE, 199 (L)Alkhulaifi AM, 304Amadi AA, 540Anderson RH, 559, 566Andrews R, 237Armstrong PW, 242Ashour S, 284Ayman M, 284

Baccillieri S, 258Ball J, 571Barker DJP, 116, 363Bamett DB, 540Bath PMW, 10Baur LHB, 227Beastall G, 41Beevers G, 584 (L)Beghetti M, 65Bellamy CM, 25Bent SE, 417Berner M, 65Berning J, 320, 506Berry C, 116Bhandari S, 110Billingham C, 173Block M, 158Bloomfield P, 391 (F)Bocker D, 158Bonarjee VVS, 506, 511Boon NA, 583 (L)Borggrefe M, 158Borland W, 41Boyle RM, 302 (E), 359, 413Brack M, 393 (L)Brawn WJ, 456, 479Breithardt G, 158Bridson JM, 99Brodie BR, 411Brooks M, 265Brouwer J, 134, 263Brown AH, 92Brunotte F, 61Bruschke AVG, 227Bu'Lock FA, 334, 340, 456Bull C, 164

Caforio ALP, 417Caidahl K, 506, 511Caillot D, 61Camesasca C, 355Camm AJ, 10Campbell NPS, 200 (L)Campbell RWF, 32Canavan C, 129Carstensen S, 506Carter R, 41Cary N, 73Castrucci M, 158Cats VM, 227Channer KS, 200 (L), 488 (L)Charles RG, 392 (L), 571Chen L, 216Chester M, 216Chester MR, 540Cheung B, 584 (L)Chierchia SL, 355Chiu RC-J, 1 (E)Choi JY, 544Choo KE, 523Choy A-MJ, 102 (L)Christie J, 466Clark AL, 445Clarkson MJ, 177Clausell N, 534, 581Coats AJ, 393 (L)Coats AJS, 395Cobbe SM, 41, 139, 466Coker SJ, 177Comerford DM, 576Connelly DT, 571Cooper JP, 169, 351Cottin Y, 61Coudert B, 61Cowan JC, 310, 397Cowell R, 103 (L)Cowley AJ, 237, 470Grsjns HIGM, 37, 103 (L), 134,

263

Cross DB, 500Cross SJ, 102 (L)Currie P, 351

Daly K, 422Daly LE, 576Daly PA, 581Darbar D, 102 (L)Dargie HJ, 466Davidson NC, 102 (L)Davies DW, 250Davies MK, 434Davis KB, 548Davis LM, 377Davis TME, 523Dawson F, 475Day INM, 368de Feyter PJ, 82De Giovanni JV, 401, 456, 479De Giovanni, 173de Groot A, 227De Jaegere PP, 407de Jaegere PP, 82de Lima VC, 534Dean J, 265Dickson D, 293Dickstein K, 511Dietz R, 517Dodds PA, 25Doherty JG, 475Doran J, 434Douglas PS, 548Dovigo P, 258Dunn FG, 527

Edner M, 506Eichhom Ch, 517Ellenbogen KA, 583 (L)Elliott MJ, 164Engvall J, 270Erbel R, 462

Fall CHD, 363Farooqi IS, 584 (L)Fastenrath C, 158Fischer JL, 293Forde A, 422Fragasso G, 355Francis CM, 390 (F)Freeman MR, 242French JK, 500Friedli B, 65Frolich M, 227Furniss SS, 32

Gaffney B, 129, 385Galatius-Jensen S, 488 (L)Galli M, 486Gandhi MM, 193Gang Y, 417Gannon F, 422Garratt CJ, 250Gatzoulis MA, 182, 445, 586 (L)Ge J, 462Gershlick AH, 393 (L)Giannico S, 355Gibbs JL, 99Gibson DG, 53, 151, 559Gilles A, 61Glennon PE, 496Goodfield NER, 110, 391 (F)Gorge G, 462Gotlieb Al, 534Graham IM, 576Gray CE, 41Gray D, 470Gray J, 265Grech ED, 414Greenwald S, 116Griffith MJ, 8, 92Grines CL, 405Guly UM, 372Gunn I, 102 (L)Gustavsson CG, 223

Haaksma J, 134Haberer T, 293Habre W, 65Hag OEL, 583 (L)Hall RJC, 302 (E)Hamer HPM, 37Hammel D, 158Hammill SC, 6Hampton JR, 470Hanlein D, 517

Hardy P, 115 (F)

Hargreaves AD, 583 (L)Hargreaves MR, 101 (L)Hart HH, 500Harvey K, 41Harwood R, 584 (L)Hassanin MM, 284Haude M, 462Hauer RNW, 442Heald SC, 250Heaviside DW, 92Henein MY, 151Henney AM, 209Henselmann L, 293Hess J, 49Hickey N, 576Higgins I, 576Higham PD, 32Ho SY, 182, 559, 566Holt PM, 76Houston AB, 383Hubner PJB, 393 (L)Humphries SE, 209, 368

Ibrahim J, 523lida H, 69Isbruch F, 158

Jagtap R, 456Jakob G, 145James MA, 392 (L)Jamieson M, 87Jamieson MPG, 277Jayawickreme SR, 169Jennings K, 102 (L)Jennings KP, 87, 125Jespersen S, 116Jin XY, 53John ASt, 523Johnston IDA, 237Jolobe OMP, 101 (L)Junker A, 320

Kane M, 422Kappenberger L, 107 (E)Karani S, 327Karlsson E, 270Kasem-Suwan P, 187Kaski JC, 216Katz A, 14Kaul S, 490Keating NA, 470Kee F, 129, 385Keeling PJ, 417Keirse MJNC, 227Kennedy NSJ, 102 (L)Kerr F, 475Khaira H, 199 (L)Kilcoyne D, 576Kim HS, 544Kinnear WJ, 237Klein GJ, 583 (L)Klein H, 20Kligfield P, 403Kofflard MJ, 82Koster JF, 208 (F)

Labovitz A, 548Lampe FC, 193Lang CC, 102 (L)Langer A, 242Latif S, 139Lavin F, 422Layton C, 199 (L)Leatham EW, 10Lee HS, 102 (L), 359Legault SE, 242Leslie RDG, 450Levy R, 14Lie KI, 37, 103 (L), 134, 263Lindsay HSJ, 397Lip GYH, 527, 584 (L), 586 (L)Little J, 129Littler WA, 122, 428Liu P, 534Lo SSS, 450Logan RW, 277Lorimer AR, 139Lote CJ, 434Louis P, 61Lowe GDO, 527Luft F, 517

Macauley D, 199 (L)Macfarlane PW, 139MairlJ, 145

Mandalia S, 209

Mandawat MK, 139Maraglino G, 258Martin RP, 334, 340Martin W, 466Martyn CN, 116Massing JL, 61Matthews D, 102 (L)McClements B, 200 (L)McConnell W, 129McEwan J, 489McKenna WJ, 417McLoughlin M, 576McNeill GP, 102 (L)Metcalfe MJ, 466Meyer J, 462Mickel MC, 548Mickley H, 320Mitchell IM, 277Mitha AS, 555Moller M, 320Molossi S, 534Morillo CA, 583 (L)Morley-Davies A, 110, 391 (F)Morris JL, 115 (F), 310Mott MG, 334, 340Mounsey JP, 92Muirhead RA, 25Mukhtar HT, 122Mulcahy D, 101 (L)Munclinger MJ, 555Murday V, 417

Nielsen JR, 320Nilsen DWT, 506, 511Noh CI, 544Norell MS, 390 (F)Norris RM, 500Nylander E, 270

Oakhill A, 340O'Brien I, 102 (L)O'Callaghan PA, 576O'Dell SD, 368Ohlin A-K, 223Ohlin H, 223Oldroyd KG, 41, 466Oliver MF, 299 (E)Oliver RM, 351Omboni S, 290Omland T, 506, 511O'Neill WW, 405Ormerod 0, 101 (L)Osmond C, 116, 363Osterziel KJ, 517O'Toole L, 200 (L)Otto CM, 548

Palatini P, 258Palmer RG, 392 (L)Pantev E, 223Papa M, 355Patel JJ, 555Patel N, 555Peart I, 190Perry RA, 25Pfitzner P, 20Pichler M, 145Plant WD, 110Politi A, 486Pollock JCS, 277Poole-Wilson PA, 496Porter J, 73Posma J. 37Potjalongsilp S, 187Prakash A, 76Pringle SD, 139Pringle TH, 102 (L)Pugsley WB, 304Puschendorf B, 145Pye M, 466

Quinn T, 359

Rabinovitch M, 534Ramsdale DR, 115 (F), 392 (L),

414Rao PS, 585 (L)Rashwan MA, 284Rawles JM, 87, 125Ray SG, 466, 571Redel DA, 383Redington AN, 182, 383, 445, 586(L)Redpath TW, 265Reid CL, 548

Reid DS, 92

587

Author Index

Richards DA, 377Riedinger-Berriolo A, 61Riesenberg K, 14Rigby ML, 182, 383, 586 (L)Riyami AAS, 139Robertson CE, 372Robinson K, 576Rose EL, 125Ross DL, 377Rowland E, 250Rumley A, 527Ruygrok P, 82

Sadiq M, 173Santoro F, 355Scheld HH, 158Schilling RJ, 390 (F)Schipperheyn nI, 227Schlaeffer F, 14Schnittger I, 306Schofield P, 73Seo H, 417Serruys PW, 82Sethia B, 456, 479Shaw TRD, 390 (F)Shearman C, 199 (L)Sheridan DJ, 428Shinebourne EA, 182Shore DF, 182Sideris EB, 585 (L)Sigwart U, 393 (L)Silove ED, 173, 456, 479Silver MD, 581Simmers TA, 442Simoons ML, 407Singh B, 523

Singh SP, 586 (L)Sluiter W, 208 (F)Smit AAJ, 290Smith FW, 265Smith G, 417Smyllie JH, 310Solimene MC, 101 (L)Song JY, 544Sonnhag C, 270Souverijn JHM, 227Sowton E, 327Spencer JL, 523Stanton MS, 6Starling R, 237Stenport G, 270Sticca M, 486Struthers AD, 102 (L)Stuart AG, 483Stumper 0, 173, 456, 479Sturaro M, 258Sugden PH, 496Sulke N, 327Sullivan ID, 164Sundsfiord JA, 511Sutherland GR, 110Sutton MStJ, 450Swanton RH, 169, 351Szab6 BM, 263

Takahashi A, 69Tan KH, 327Taub N, 327Telford AM, 129Thorvinger B, 223Tieleman RG, 37Timmers T, 49

Timmis AD, 103 (L)Tisi P, 199 (L)Tobe TJM, 108Tometzki AJP, 383Toniolo G, 258Tooze JA, 10Toubeau M, 61Touzery C, 61Townend JN, 434Trappe H-J, 20Trent RJ, 87, 125, 265Tulloh RMR, 164Turley E, 534

Uther JB, 377

Vaitkus PT, 409van Boven AJ, 134van den Berg MP, 263van den Brand M, 82van den Heuvel F, 49van der Laarse A, 227van Domburg R, 82Vijayakumar M, 363Vogel M, 566Voogd PJ, 227Vroom TFFP, 227

Walker JM, 351Walker P, 61Walker SK, 392 (L)Wallbridge DR, 139, 488 (L)Walsh JT, 237, 470Walsh KP, 177Walsh MJ, 576Walton S, 265Wang K, 559

Ward DE, 250Watson JD, 129Watts GF, 209Welch JC, 99Wenzlaff P, 20Westaby S, 203 (E)Wever EFD, 442White HD, 500Wieling W, 290Wiesfeld ACP, 37Willenbrock R, 517Williams BF, 500Wilmshurst P, 236 (F)Wilson AT, 488 (L)Wilson DG, 483Wilson N, 383Wisheart JD, 483Wittkampf FHM, 442WolfJE, 61Wood DA, 4 (E), 193Wranne B, 270Wright BY, 392 (L)Wright JGC, 173, 456, 479Wright JS, 103 (L)

Xiao HB, 53

Ye S, 209Yoshimura M, 585 (L)Youhana AY, 206 (F)Yun YS, 544

Zaman AG, 310, 397Zeina A-AA, 284Zijlstra F, 403Zoia E, 355

588

Br Heart J 1995;73:589-594

VOLUME 73 - SUBJECT INDEX

Ablation, Simultaneous mapping of the tricuspid and mitral valveannuli at electrophysiological study 377

Acadesine, Role of acadesine in clinical myocardial protection 304Access, Expanding access to coronary artery bypass surgery 129Accessory pathway, Simultaneous mapping of the tricuspid and

mitral valve annuli at electrophysiological study 377ACE gene polymorphisms, Rapid methods for population-scale

analysis for gene polymorphisms 368ACE inhibitorsACE for whom? Implications for clinical practice of post-infarct

trials 470ACE inhibitors after myocardial infarction 395, 397Combining salicylate and enalapril in patients with coronary

artery disease and heart failure 227Do radionuclide and echocardiographic techniques give a universal

cut off value for left ventricular ejection fraction that can beused to select patients for treatment with ACE inhibitors aftermyocardial infarction? 466

Responses of plasma concentrations of A type natriuretic peptideand B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heartfailure 584

Active compression-decompression device, Active decompres-sion improves the haemodynamic state during cardiopulmonaryresuscitation 372

Acute inferior myocardial infarction, Is thrombolytic therapy inacute inferior myocardial infarction really better than conven-

tional treatment? 108Acute myocardial infarction

Delay between the onset of symptoms of acute myocardial infarc-tion and seeking medical assistance is influenced by left ventric-ular function at presentation 125

Experience of primary angioplasty in the UK 414Immediate angioplasty 407Immediate angioplasty in the United Kingdom 413Left ventricular volumes, ejection fraction, and plasma proatrial

natriuretic factor (1-98) after withdrawal of enalapril treatmentinitiated early after myocardial infarction 506

Limitations of primary angioplasty in acute myocardial infarction409

Primary angioplasty 405Primary angioplasty in a community hospital in the USA 411Primary angioplasty in acute myocardial infarction 403Primary angioplasty is the most effective treatment for an acutemyocardial infarction 403

Prognostic significance of transient myocardial ischaemia afterfirst acute myocardial infarction 320

Survival after acute myocardial infarction in Asian and whitepatients in Birmingham 122

Adenosine, Haemodynamic deterioration after treatment withadenosine 103

adrenoceptor downregulation, adrenoceptor density in thedonor heart 540

Adult arterial compliance, Growth in utero, adult blood pressure,and arterial compliance 116

Adverse coronary events, Identification of patients at high risk foradverse coronary events while awaiting routine coronary angio-plasty 216

Advisers, List of advisers 394Agism

Issues in cardiac pacing 101Women and myocardial infarction 87

Alacepril, Responses of plasma concentrations ofA type natriureticpeptide and B type natriuretic peptide to alacepril, an

angiotensin-converting enzyme inhibitor, in patients with con-

gestive heart failure 584Alcohol, New year toast...to the cardioprotective effects of alcohol 8Angina

Incidence, clinical characteristics, and short-term prognosis ofangina pectoris 193

Vasoconstrictor peptides and cold intolerance in patients withstable angina pectoris 25

Angiography, Are the economically active more deserving? 385Angioplasty

Efficacy of a third coronary angioplasty for a second restenosis 327Guide wire graffito 505

Anomalous pulmonary venous connection, Fetal echocardiogra-

phy in detecting anomalous pulmonary venous connection 355Anthracycline

Impairment of diastolic function during short-term anthracyclinechemotherapy 61

Left ventricular diastolic function after anthracycline chemother-apy in childhood 340

Anticoagulation, Anticoagulation after intracoronary stent inser-tion 393

Systemic thromboembolism leading to myocardial infarction andstroke after fenestrated total cavopulmonary connection 483

Antioxidants, Antioxidant nutrients, atherosclerosis, and coronaryheart disease 299

Antiviral therapy, Potential for antiviral therapy in the treatmentof restenosis after angioplasty 489

Aortic coarctationArm-ankle systolic blood pressure difference at rest and after exer-

cise in the assessment of aortic coarctation 270Mitral valve hypoplasia in children with isolated coarctation of the

aorta 199Aortic elastic properties, Aortic distensibility and stiffness index

measured by magnetic resonance imaging in patients withMarfan's syndrome 265

Aortic stenosisComparison of Doppler echocardiographic methods with heart

catheterisation in assessing aortic valve area in 100 patients withaortic stenosis 293

Gender differences in left ventricle geometry and function inpatients undergoing balloon dilatation of the aortic valve forisolated aortic stenosis 548

Nitrates and severe aortic stenosis 586Aortic valve area, Comparison of Doppler echocardiographic

methods with heart catheterisation in assessing aortic valve areain 100 patients with aortic stenosis 293

Arterial duct, Responses of the post-term arterial duct to oxygen,prostaglandin E2, and the nitric oxide donor, 3-morpholinosyd-nonimine, in lambs and their clinical implications 177

Asians, Insulin resistance, high prevalence of diabetes, and cardio-vascular risk in immigrant Asians 584

Asymptomatic ischaemia, Asymptomatic ischaemia during dailylife in stable coronary artery disease 101

AtherosclerosisAntioxidant nutrients, atherosclerosis, and coronary heart disease299

High wall shear stress proximal to myocardial bridging and athero-sclerosis 462

Is increased tissue ferritin a risk factor for atherosclerosis andischaemic heart disease? 208

Atrial anatomy, Architecture of atrial musculature in humans 559Atrial fibrillation

Increased markers of thrombogenesis in chronic atrial fibrillation527

Value of transoesophageal echocardiography before DC cardio-version in patients with atrial fibrillation 306

Atrial flutter, Effect of exercise on cycle length in atrial flutter 263Atrial muscles, Architecture of atrial musculature in humans 559Atrioventricular conduction, Change in delay of atrioventricular

conduction after radiofrequency catheter ablation for atrioven-tricular nodal re-entry tachycardia 442

Atrioventricular node, Change in delay of atrioventricular con-duction after radiofrequency catheter ablation for atrioventricu-lar nodal re-entry tachycardia 442

Audit ofpacemaker practice, Permanent pacemaker practice at aScottish district general hospital between 1987 and 1993 475

Autonomic failure, Twenty four hour continuous non-invasivefinger blood pressure monitoring 290

Autonomic nervous system, Differential autonomic mechanismsunderlying early morning and daytime transient myocardialischaemia in patients with stable coronary artery disease 134

Birth weight, Birth weight, weight at one year, and left ventricularmass in adult life 363

Bjork-Shiley mitral valve prosthesis, Strut fracture of theConvexo-Concave Bjork-Shiley mitral valve prosthesis 391

Blalock-Taussig shunts, Closure of Blalock-Taussig shunts using anew detachable coil device 383

589

Subject Index

Blood pressureArm-ankle systolic blood pressure difference at rest and after exer-

cise in the assessment of aortic coarctation 270Growth in utero, adult blood pressure, and arterial compliance116

Body surface area, Left ventricular diastolic function in childrenmeasured by Doppler echocardiography 334

British Cardiac Society, Report of a working group of the BritishCardiac Society 201

CaptoprilEffects of captopril and oxygen on sleep apnoea in patients withmild to moderate congestive cardiac failure 237

Peripheral haemodynamic effects of inhibition of prostaglandinsynthesis in congestive heart failure and interactions with capto-pril 434

Cardiac catheterisation, Comparison of Doppler echocardio-graphic methods with heart catheterisation in assessing aorticvalve area in 100 patients with aortic stenosis 293

Cardiac defects, Transcatheter occlusion of cardiac defects 585Cardiac failure, 0) adrenoceptor density in the donor heart 540Cardiac function, Plasma proatrial natriuretic factor (1-98) con-

centration after myocardial infarction 511Cardiac hypertrophy, Cellular mechanisms of cardiac hypertro-

phy 496Cardiac marker proteins, Comparison of five cardiac markers in

the detection of reperfusion after thrombolysis in acute myocar-dial infarction 422

Cardiac surgery, Continuous low dose inhaled nitric oxide fortreatment of severe pulmonary hypertension after cardiacsurgery in paediatric patients 65

Cardiac tamponade, How do the clinical findings in patients withpericardial effusions influence the success of aspiration? 351

Cardiac transplantationfi adrenoceptor density in the donor heart 540Atheroembolism in an endomyocardial biopsy from a cardiac

transplant recipient after coronary angioplasty 581Cardiomyoplasty, Dynamic cardiomyoplasty for heart failure 1Cardioplegia, Warm blood cardioplegia 206Cardioprotection, New year toast...to the cardioprotective effects

of alcohol 8Cardiopulmonary bypass, Coronary surgery without cardiopul-

monary bypass 203Cardiopulmonary resuscitation, Active decompression improves

the haemodynamic state during cardiopulmonary resuscitation372

Cardiovascular disease, Birth weight, weight at one year, and leftventricular mass in adult life 363

Cardioversion, Value of transoesophageal echocardiography beforeDC cardioversion in patients with atrial fibrillation 306

Cardioverter-defibrillatorBenefits of treatment with implantable cardioverter-defibrillators

in patients with stable ventricular tachycardia without cardiacarrest 158

Implantation of cardioverter-defibrillators at district general hos-pitals 392

Infections after cardioverter-defibrillator implantation 20Catheter ablation, Change in delay of atrioventricular conduction

after radiofrequency catheter ablation for atrioventricular nodalre-entry tachycardia 442

Cellular mechanisms, Cellular mechanisms of cardiac hypertro-phy 496

Central venous cannulation, Safety of thrombolytic treatment inpatients with central venous cannulation 359

Chelation therapy, Reversal ofhaemochromatotic cardiomyopathyin 0 thalassaemia by chelation therapy 486

ChildrenContinuous low dose inhaled nitric oxide for treatment of severepulmonary hypertension after cardiac surgery in paediatricpatients 65

Nutritional status of children with congenital heart disease 277Twiddler's syndrome in children 190Ventricular tachycardia and exercise related syncope in childrenwith structurally normal hearts 544

Cholesterol lowering, Cholesterol lowering does have a role insecondary prevention 4

Clinical trialsACE for whom? Implications for clinical practice of post-infarct

trials 470ACE inhibitors after myocardial infarction 395, 397

Cold intolerance, Vasoconstrictor peptides and cold intolerance inpatients with stable angina pectoris 25

Complications of permanent pacing, Early complications ofpermanent pacemaker implantation 571

Congenital heart defectsCombined atrial and arterial switch procedure for congenitalcorrected transposition with ventricular septal defect 479

Increasing cyanosis early after cavopulmonary connection causedby abnormal systemic venous channels 182

Influence of ethnic origin on the pattern of congenital heartdefects in the first year of life 173

Congenital heart diseaseComparison of three dimensional echocardiographic findings withanatomical specimens of various congenitally malformed hearts566

Nutritional status of children with congenital heart disease 277Congestive heart failure

Effects of captopril and oxygen on sleep apnoea in patients withmild to moderate congestive cardiac failure 237

Peripheral haemodynamic effects of inhibition of prostaglandinsynthesis in congestive heart failure and interactions with capto-pril 434

Responses of plasma concentrations of A type natriuretic peptideand B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heartfailure 584

Constrictive pericarditis, Predictors of constrictive pericarditisafter tuberculous pericarditis 187

Continuous finger blood pressure monitoring, Twenty four hourcontinuous non-invasive finger blood pressure monitoring 290

Convexo-concave, Strut fracture of the Convexo-Concave Bjork-Shiley mitral valve prosthesis 391

Coronary angioplastyAtheroembolism in an endomyocardial biopsy from a cardiac

transplant recipient after coronary angioplasty 581Identification of patients at high risk for adverse coronary eventswhile awaiting routine coronary angioplasty 216

Immediate and long-term clinical outcome of coronary angio-plasty in patients aged 35 years or less 82

Coronary artery bypass surgeryCoronary surgery without cardiopulmonary bypass 203Determinants of the length of stay in intensive care and in hospital

after coronary artery surgery 92Expanding access to coronary artery bypass surgery 129

Coronary artery diseaseCholesterol lowering does have a role in secondary prevention 4Differential autonomic mechanisms underlying early morning anddaytime transient myocardial ischaemia in patients with stablecoronary artery disease 134

Increased monocyte tissue factor expression in coronary disease10

Pathophysiology and time course of silent myocardial ischaemiaduring mental stress 242

Coronary artery vasospasm, Positron emission tomography withoxygen-15 of stunned myocardium caused by coronary arteryvasospasm after recovery 69

Coronary atheroembolism, Atheroembolism in an endomyocar-dial biopsy from a cardiac transplant recipient after coronaryangioplasty 581

Coronary care units, National perspective of acute coronary carein the Republic of Ireland 576

Coronary heart diseaseAntioxidant nutrients, atherosclerosis, and coronary heart disease299

National perspective of acute coronary care in the Republic ofIreland 576

Coronary microcirculation, Assessment of coronary microcircu-lation with myocardial contrast echocardiography 490

Corrected transposition, Combined atrial and arterial switch pro-cedure for congenital corrected transposition with ventricularseptal defect 479

Cyanosis, Increasing cyanosis early after cavopulmonary connec-tion caused by abnormal systemic venous channels 182

Cycle length, Effect of exercise on cycle length in atrial flutter 263Cyclic guanosine monophosphate (cGMP), Ergometric exercise

testing and sensitivity of cyclic guanosine 3 ',5 '-monophosphate(cGMP) in diagnosing asymptomatic left ventricular dysfunc-tion 145

Cytokines, Expression of tumour necrosis factor a and accumula-tion of fibronectin in coronary artery restenotic lesions retrievedby atherectomy 534

590

Subject Index

Daytime transient myocardial ischaemia, Differential auto-nomic mechanisms underlying early morning and daytime tran-sient myocardial ischaemia in patients with stable coronaryartery disease 134

Diabetes, Effects of type 1 diabetes mellitus on cardiac function 450Diastolic fimction, Impairment of diastolic function during short-

term anthracycline chemotherapy 61Direct access, Direct access exercise electrocardiography 199District general hospital

Electrophysiology in a district general hospital 76Permanent pacemaker practice at a Scottish district general hospi-

tal between 1987 and 1993 475District general hospitals, Implantation of cardioverter-defibrilla-

tors at district general hospitals 392Diuretics, Please Sir! GPs treat cardiac failure too! 199Doppler echocardiography

Comparison of Doppler echocardiographic methods with heartcatheterisation in assessing aortic valve area in 100 patients withaortic stenosis 293

Left ventricular diastolic function after anthracycline chemother-apy in childhood 340

Left ventricular diastolic function in children measured byDoppler echocardiography 334

Doppler measurement, Doppler reconstruction of left ventricularpressure from functional mitral regurgitation 53

Dual chamber pacing, Early complications of permanent pace-maker implantation 571

Dyspnoea, "Why am I short of breath, doctor?" 393

Early diagnosis, Will serum enzymes and other proteins find a clin-ical application in the early diagnosis of myocardial infarction?102

EchocardiographyComparison of three dimensional echocardiographic findings withanatomical specimens of various congenitally malformed hearts566

Do radionuclide and echocardiographic techniques give a universalcut off value for left ventricular ejection fraction that can beused to select patients for treatment with ACE inhibitors aftermyocardial infarction? 466

Economic activity, Are the economically active more deserving?385

ElectrophysiologyElectrophysiology in a district general hospital 76Simultaneous mapping of the tricuspid and mitral valve annuli at

electrophysiological study 377Embolism, Value of transoesophageal echocardiography before DC

cardioversion in patients with atrial fibrillation 306Enalapril withdrawal, Left ventricular volumes, ejection fraction,

and plasma proatrial natriuretic factor (1-98) after withdrawalof enalapril treatment initiated early after myocardial infarction506

Endogenous opioids, Activation and inhibition of the endogenousopioid system in human heart failure 41

Endomyocardial biopsy, Atheroembolism in an endomyocardialbiopsy from a cardiac transplant recipient after coronary angio-plasty 581

Endomyocardial fibrosis, Endomyocardial fibrosis in Egypt 284Endorphins, Increase in plasma ,B endorphins precedes vasodepres-

sor syncope 488Enlarged coronary sinus and superior vena cava, Fetal

echocardiography in detecting anomalous pulmonary venousconnection 355

Enoximone, Quality of life in heart failure treated with enoximone584

Ethnic originInfluence of ethnic origin on the pattern of congenital heart

defects in the first year of life 173Survival after acute myocardial infarction in Asian and white

patients in Birmingham 122Exercise, Ventricular tachycardia and exercise related syncope in

children with structurally normal hearts 544Exercise capacity, Ventilatory responses to exercise in adults after

repair of tetralogy of Fallot 445Exercise testing

Arm-ankle systolic blood pressure difference at rest and after exer-cise in the assessment of aortic coarctation 270

Direct access exercise electrocardiography 199Effect of exercise on cycle length in atrial flutter 263Ergometric exercise testing and sensitivity of cyclic guanosine

3',5'-monophosphate (cGMP) in diagnosing asymptomatic leftventricular dysfunction 145

Placebo controlled trial of felodipine in patients with mild to mod-erate heart failure 428

Familial dilated cardiomyopathy, Familial dilated cardiomyopa-thy in the United Kingdom 417

Fast track, Determinants of the length of stay in intensive care andin hospital after coronary artery surgery 92

Felodipine, Placebo controlled trial of felodipine in patients withmild to moderate heart failure 428

Fenestrated total cavopulmonary shunt, Systemic thromboem-bolism leading to myocardial infarction and stroke after fenes-trated total cavopulmonary connection 483

Ferritin, Is increased tissue ferritin a risk factor for atherosclerosisand ischaemic heart disease? 208

Fetal echocardiography, Fetal echocardiography in detectinganomalous pulmonary venous connection 355

Fetal growth, Growth in utero, adult blood pressure, and arterialcompliance 116

Gender, Gender differences in left ventricle geometry and function inpatients undergoing balloon dilatation of the aortic valve for iso-lated aortic stenosis 548

General practitioners, Direct access exercise electrocardiography199

Gingival hyperplasia, Gingival hyperplasia with nifedipine 115Graffito, Guide wire graffito 505

HaemochromatosisHaemochromatosis presenting as congestive cardiac failure 73Reversal of haemochromatotic cardiomyopathy in ,B thalassaemiaby chelation therapy 486

Haemodynamic and renal effects of indomethacin, Peripheralhaemodynamic effects of inhibition of prostaglandin synthesis incongestive heart failure and interactions with captopril 434

Haemodynamic deterioration, Haemodynamic deteriorationafter treatment with adenosine 103

Haemodynamic state during cardiopulmonary resuscitation,Active decompression improves the haemodynamic state duringcardiopulmonary resuscitation 372

Heart failureACE inhibitors after myocardial infarction 395, 397Activation and inhibition of the endogenous opioid system inhuman heart failure 41

Baroreflex sensitivity and cardiovascular mortality in patients withmild to moderate heart failure 517

Combining salicylate and enalapril in patients with coronaryartery disease and heart failure 227

Dynamic cardiomyoplasty for heart failure 1Ergometric exercise testing and sensitivity of cyclic guanosine3',5'-monophosphate (cGMP) in diagnosing asymptomatic leftventricular dysfunction 145

Haemochromatosis presenting as congestive cardiac failure 73Placebo controlled trial of felodipine in patients with mild to mod-

erate heart failure 428Please Sir! GPs treat cardiac failure too! 199Quality of life in heart failure treated with enoximone 584

Heart rate variability, Heart rate variability in left ventricularhypertrophy 139

Heparin, Inhibition of superoxide production in human neutrophilsby combinations of heparin and thrombolytic agents 14

Hypertension, Impaired left ventricular filling in hypertensive leftventricular hypertrophy as a marker of the presence of anarrhythmogenic substrate 258

Hypertrophic cardiomyopathy, Pacing for obstructive hyper-trophic cardiomyopathy 107

Hypocalcaemia, Dynamic assessment of the electrocardiographicQT interval during citrate infusion in healthy volunteers 523

Hypoplastic systemic ventricle, Surgery for infants with ahypoplastic systemic ventricle and severe outflow obstruction456

Hysteresis, Dynamic assessment of the electrocardiographic QTinterval during citrate infusion in healthy volunteers 523

Idiopathic dilated cardiomyopathy, Familial dilated cardiomy-opathy in the United Kingdom 417

Implantable defibrillators, Use of the implantable defibrillator 6Incidence, Incidence, clinical characteristics, and short-term prog-

nosis of angina pectoris 193

591

Subject Index

Infancy, Influence of ethnic origin on the pattern of congenitalheart defects in the first year of life 173

Infection, Infections after cardioverter-defibrillator implantation 20Inferior vena cava, Leiomyosarcoma in the right atrium and

occluding the inferior vena cava 236Inflammatory cells, Expression of tumour necrosis factor a and

accumulation of fibronectin in coronary artery restenotic lesionsretrieved by atherectomy 534

Inoue balloon rupture, Inoue balloon rupture during dilatation ofcalcified mitral valves 390

Insulin resistance, Insulin resistance, high prevalence of diabetes,and cardiovascular risk in immigrant Asians 584

Intensive care stay, Determinants of the length of stay in intensivecare and in hospital after coronary artery surgery 92

Interventional closure, Closure of Blalock-Taussig shunts using anew detachable coil device 383

Intracoronary pressureHigh wall shear stress proximal to myocardial bridging and athero-

sclerosis 462Pathophysiology and time course of silent myocardial ischaemiaduring mental stress 242

Ischaemia, Prognostic significance of transient myocardialischaemia after first acute myocardial infarction 320

Ischaemic heart disease, Direct access exercise electrocardiogra-phy 199

Left ventricular diastolic function, Suppression of left ventricularearly diastolic filling by long axis asynchrony 151

Left ventricular diastolic function in childrenLeft ventricular diastolic function after anthracycline chemother-apy in childhood 340

Left ventricular diastolic function in children measured byDoppler echocardiography 334

Left ventricular dilatation, Left ventricular volumes, ejectionfraction, and plasma proatrial natriuretic factor (1-98) afterwithdrawal of enalapril treatment initiated early after myocar-dial infarction 506

Left ventricular dysfunctionDetection of left ventricular dysfunction after myocardial infarc-

tion 101Ergometric exercise testing and sensitivity of cyclic guanosine3',5'-monophosphate (cGMP) in diagnosing asymptomatic leftventricular dysfunction 145

Left ventricular ejection fraction, Do radionuclide and echocar-diographic techniques give a universal cut off value for left ven-tricular ejection fraction that can be used to select patients fortreatment with ACE inhibitors after myocardial infarction? 466

Left ventricular enlargement, Birth weight, weight at one year,and left ventricular mass in adult life 363

Left ventricular fimctionDelay between the onset of symptoms of acute myocardial infarc-

tion and seeking medical assistance is influenced by left ventric-ular function at presentation 125

Pathophysiology and time course of silent myocardial ischaemiaduring mental stress 242

Left ventricular hypertrophyHeart rate variability in left ventricular hypertrophy 139Impaired left ventricular filling in hypertensive left ventricularhypertrophy as a marker of the presence of an arrhythmogenicsubstrate 258

Left ventricular mass, Gender differences in left ventricle geometryand function in patients undergoing balloon dilatation of theaortic valve for isolated aortic stenosis 548

Lipid peroxidation products, Transient release of lipid peroxida-tion products as a non-invasive marker of successful reperfusionafter thrombolysis for myocardial infarction 223

Long axis asynchrony, Suppression of left ventricular early dias-tolic filling by long axis asynchrony 151

Magnetic resonance imaging, Aortic distensibility and stiffnessindex measured by magnetic resonance imaging in patients withMarfan's syndrome 265

Mahaim pathways, Radiofrequency catheter ablation of Mahaimtachycardia by targeting Mahaim potentials at the tricuspidannulus 250

Marfan's syndrome, Aortic distensibility and stiffness index mea-sured by magnetic resonance imaging in patients with Marfan'ssyndrome 265

Matrix, Expression of tumour necrosis factor a and accumulation offibronectin in coronary artery restenotic lesions retrieved byatherectomy 534

Medical devices, Medical devices 401Mental stress, Pathophysiology and time course of silent myocar-

dial ischaemia during mental stress 242Mitral regurgitation, Doppler reconstruction of left ventricular

pressure from functional mitral regurgitation 53Mitral stenosis, Percutaneous balloon dilatation of the mitral valve

in critically ill young patients with intractable heart failure 555Mitral valve calcification, Inoue balloon rupture during dilatation

of calcified mitral valves 390Mitral valve hypoplasia, Mitral valve hypoplasia in children with

isolated coarctation of the aorta 199Mitral valve prolapse, Increased dispersion of refractoriness in the

absence of QT prolongation in patients with mitral valve pro-lapse and ventricular arrhythmias 37

Monocytes, Increased monocyte tissue factor expression in coro-nary disease 10

Myocardial bridging, High wall shear stress proximal to myocar-dial bridging and atherosclerosis 462

Myocardial contrast echocardiography, Assessment of coronarymicrocirculation with myocardial contrast echocardiography490

Myocardial infarctionACE for whom? Implications for clinical practice of post-infarct

trials 470ACE inhibitors after myocardial infarction 395, 397Detection of left ventricular dysfunction after myocardial infarc-

tion 101Nitrates in myocardial infarction 310Nocturnal hypoxaemia after myocardial infarction 488Plasma proatrial natriuretic factor (1-98) concentration aftermyocardial infarction 511

QT dispersion and components of the QT interval in ischaemiaand infarction 32

Safety of thrombolytic treatment in patients with central venouscannulation 359

Transient release of lipid peroxidation products as a non-invasivemarker of successful reperfusion after thrombolysis for myocar-dial infarction 223

Will serum enzymes and other proteins find a clinical application inthe early diagnosis of myocardial infarction? 102

Women and myocardial infarction 87Myocardial protection, Role of acadesine in clinical myocardial

protection 304Myocarditis and aortitis, Cardiac involvement in Wegener's gran-

ulomatosis 110

Natriuretic peptides A and B, Responses of plasma concentra-tions ofA type natriuretic peptide and B type natriuretic peptideto alacepril, an angiotensin-converting enzyme inhibitor, inpatients with congestive heart failure 584

Neutrophils, Inhibition of superoxide production in human neu-trophils by combinations of heparin and thrombolytic agents 14

Nifedipine, Gingival hyperplasia with nifedipine 115Nitrates

Nitrates and severe aortic stenosis 586Nitrates in myocardial infarction 310

Nitric oxideContinuous low dose inhaled nitric oxide for treatment of severepulmonary hypertension after cardiac surgery in paediatricpatients 65

Responses of the post-term arterial duct to oxygen, prostaglandinE2, and the nitric oxide donor, 3-morpholinosydnonimine, inlambs and their clinical implications 177

Nocturnal hypoxaemia, Nocturnal hypoxaemia after myocardialinfarction 488

Non-clinical factors, Are the economically active more deserving?385

Norwood procedure, Surgery for infants with a hypoplastic sys-temic ventricle and severe outflow obstruction 456

Nutritional status, Nutritional status of children with congenitalheart disease 277

Oxygen treatmentEffects of captopril and oxygen on sleep apnoea in patients withmild to moderate congestive cardiac failure 237

Responses of the post-term arterial duct to oxygen, prostaglandinE2, and the nitric oxide donor, 3-morpholinosydnonimine, inlambs and their clinical implications 177

592

Subject Index

Pacemaker failure, Twiddler's syndrome in children 190Pacemaker infection, Antibiotic prophylaxis in permanent pace-

maker implantation 392Pacing

Issues in cardiac pacing 101Pacing for obstructive hypertrophic cardiomyopathy 107Permanent pacing in patients with tricuspid valve replacements169

Permanent pacemaker practice at a Scottish district general hospi-tal between 1987 and 1993 475

Paediatric surgery, Combined atrial and arterial switch procedurefor congenital corrected transposition with ventricular septaldefect 479

Palliation, Surgery for infants with a hypoplastic systemic ventricleand severe outflow obstruction 456

Paradoxical embolism, Near miss paradoxical embolism 103Parasympathetic nervous system, Baroreflex sensitivity and car-

diovascular mortality in patients with mild to moderate heartfailure 517

Patient delay, Delay between the onset of symptoms of acutemyocardial infarction and seeking medical assistance is influ-enced by left ventricular function at presentation 125

Peel index, Detection of left ventricular dysfunction after myocar-dial infarction 101

Percutaneous balloon dilatation, Percutaneous balloon dilatationof the mitral valve in critically ill young patients with intractableheart failure 555

Pericardial effusion, How do the clinical findings in patients withpericardial effusions influence the success of aspiration? 351

Peripheral vascular disease, Peripheral vascular disease 199Polymorphism, Genetic variation in human stromelysin promoter is

associated with progression of coronary atherosclerosis 209Population analysis, Rapid methods for population-scale analysis

for gene polymorphisms 368Positron emission tomography, Positron emission tomography

with oxygen-15 of stunned myocardium caused by coronaryartery vasospasm after recovery 69

Pregnancy, Percutaneous balloon dilatation of the mitral valve incritically ill young patients with intractable heart failure 555

Prevention of reinfarction, Combining salicylate and enalapril inpatients with coronary artery disease and heart failure 227

Primary angioplastyExperience of primary angioplasty in the UK 414Immediate angioplasty 407Immediate angioplasty in the United Kingdom 413Limitations of primary angioplasty in acute myocardial infarction409

Primary angioplasty 405Primary angioplasty in a community hospital in the USA 411Primary angioplasty in acute myocardial infarction 403Primary angioplasty is the most effective treatment for an acutemyocardial infarction 403

Proatrial natriuretic factor (1-98), Plasma proatrial natriureticfactor (1-98) concentration after myocardial infarction 511

PrognosisBaroreflex sensitivity and cardiovascular mortality in patients withmild to moderate heart failure 517

Incidence, clinical characteristics, and short-term prognosis ofangina pectoris 193

Prognostic significance of transient myocardial ischaemia afterfirst acute myocardial infarction 320

Progression of coronary artery disease, Genetic variation inhuman stromelysin promoter is associated with progression ofcoronary atherosclerosis 209

Prophylaxis, Antibiotic prophylaxis in permanent pacemakerimplantation 392

Prospective screening study, Familial dilated cardiomyopathy inthe United Kingdom 417

Prostaglandin, Combining salicylate and enalapril in patients withcoronary artery disease and heart failure 227

ProstaglandinsPeripheral haemodynamic effects of inhibition of prostaglandin

synthesis in congestive heart failure and interactions with capto-pril 434

Responses of the post-term arterial duct to oxygen, prostaglandinE2, and the nitric oxide donor, 3-morpholinosydnonimine, inlambs and their clinical implications 177

Pulmonary hypertensionContinuous low dose inhaled nitric oxide for treatment of severepulmonary hypertension after cardiac surgery in paediatricpatients 65

Endotracheal tolazoline for severe persistent pulmonary hyper-tension of the newbom 99

QT dispersion, Increased dispersion of refractoriness in theabsence of QT prolongation in patients with mitral valve pro-lapse and ventricular arrhythmias 37

QT intervalDynamic assessment of the electrocardiographic QT interval dur-

ing citrate infusion in healthy volunteers 523QT dispersion and components of the QT interval in ischaemiaand infarction 32

Quality of life, Quality of life in heart failure treated with enoxi-mone 584

Radiofrequency ablation, Radiofrequency catheter ablation ofMahaim tachycardia by targeting Mahaim potentials at the tri-cuspid annulus 250

Radionuclide angiographyDo radionuclide and echocardiographic techniques give a universal

cut off value for left ventricular ejection fraction that can beused to select patients for treatment with ACE inhibitors aftermyocardial infarction? 466

Impairment of diastolic function during short-term anthracyclinechemotherapy 61

Rapid genotyping, Rapid methods for population-scale analysis forgene polymorphisms 368

Recurrence, Supravalvar mitral stenosis 164Referral decisions, Are the economically active more deserving?

385Regulations, Medical devices 401Rehabilitation, Report of a working group of the British Cardiac

Society 201Relative wall thickness, Gender differences in left ventricle geom-

etry and function in patients undergoing balloon dilatation ofthe aortic valve for isolated aortic stenosis 548

Renal function, Plasma proatrial natriuretic factor (1-98) concen-tration after myocardial infarction 511

Renin-angiotensin-system, Baroreflex sensitivity and cardiovas-cular mortality in patients with mild to moderate heart failure517

ReperfusionComparison of five cardiac markers in the detection of reperfusion

after thrombolysis in acute myocardial infarction 422Transient release of lipid peroxidation products as a non-invasivemarker of successful reperfusion after thrombolysis for myocar-dial infarction 223

Repolarisation, Ventricular tachycardia and exercise related syn-cope in children with structurally normal hearts 544

Republic ofIreland, National perspective of acute coronary care inthe Republic of Ireland 576

RestenosisEfficacy of a third coronary angioplasty for a second restenosis 327Expression of tumour necrosis factor a and accumulation of

fibronectin in coronary artery restenotic lesions retrieved byatherectomy 534

Potential for antiviral therapy in the treatment of restenosis afterangioplasty 489

Revascularisation, Efficacy of a third coronary angioplasty for asecond restenosis 327

Right atrial leiomyosarcoma, Leiomyosarcoma in the rightatrium and occluding the inferior vena cava 236

Right ventricular dominance, Fetal echocardiography in detect-ing anomalous pulmonary venous connection 355

Risk stratification, Identification of patients at high risk foradverse coronary events while awaiting routine coronary angio-plasty 216

Schistosomiasis, Endomyocardial fibrosis in Egypt 284Secondary prevention, Cholesterol lowering does have a role in

secondary prevention 4Serum enzymes, Will serum enzymes and other proteins find a

clinical application in the early diagnosis of myocardial infarc-tion? 102

Sexism, Women and myocardial infarction 87Single chamber pacing, Early complications of permanent pace-

maker implantation 571Sleep apnoea, Effects of captopril and oxygen on sleep apnoea in

patients with mild to moderate congestive cardiac failure 237Speedwell study, Peripheral vascular disease 199ST depression, Effects of streptokinase in patients presenting

593

Subject Index

within 6 hours of prolonged chest pain with ST segment depres-sion 500

ST segment depression, Detection of left ventricular dysfunctionafter myocardial infarction 101

Stenting, Anticoagulation after intracoronary stent insertion 393Stromelysin, Genetic variation in human stromelysin promoter is

associated with progression of coronary atherosclerosis 209Strut fracture, Strut fracture of the Convexo-Concave Bjork-Shiley

mitral valve prosthesis 391Stunned myocardium, Positron emission tomography with oxy-

gen-15 of stunned myocardium caused by coronary arteryvasospasm after recovery 69

Superoxide production, Inhibition of superoxide production inhuman neutrophils by combinations of heparin and throm-bolytic agents 14

Supravalvar mitral stenosis, Supravalvar mitral stenosis 164Surgery, Increasing cyanosis early after cavopulmonary connection

caused by abnormal systemic venous channels 182Surgical resection, Supravalvar mitral stenosis 164Survival after original infarct, Survival after acute myocardial

infarction in Asian and white patients in Birmingham 122SyncopeHead-up tilt testing 583Increase in plasma ,B endorphins precedes vasodepressor syncope488

Ventricular tachycardia and exercise related syncope in childrenwith structurally normal hearts 544

Tachycardia, Radiofrequency catheter ablation of Mahaim tachy-cardia by targeting Mahaim potentials at the tricuspid annulus250

Tetralogy of Fallot, Ventilatory responses to exercise in adults afterrepair of tetralogy of Fallot 445

p thalassaemia, Reversal of haemochromatotic cardiomyopathy in/1 thalassaemia by chelation therapy 486

Three dimensional reconstruction, Comparison of three dimen-sional echocardiographic findings with anatomical specimens ofvarious congenitally malformed hearts 566

Thromboembolism, Systemic thromboembolism leading tomyocardial infarction and stroke after fenestrated total cavopul-monary connection 483

Thrombolysis, Comparison of five cardiac markers in the detectionof reperfusion after thrombolysis in acute myocardial infarction422

Thrombolytic agents, Inhibition of superoxide production inhuman neutrophils by combinations of heparin and throm-bolytic agents 14

Thrombolytic treatmentEffects of streptokinase in patients presenting within 6 hours ofprolonged chest pain with ST segment depression 500

Is thrombolytic therapy in acute inferior myocardial infarctionreally better than conventional treatment? 108

Transient release of lipid peroxidation products as a non-invasivemarker of successful reperfusion after thrombolysis for myocar-dial infarction 223

National perspective of acute coronary care in the Republic ofIreland 576

Safety of thrombolytic treatment in patients with central venouscannulation 359

Thrombotic markers, Increased markers of thrombogenesis inchronic atrial fibrillation 527

Tilt testing, Head-up tilt testing 583Tissue factor, Increased monocyte tissue factor expression in coro-

nary disease 10Tolazoline, Endotracheal tolazoline for severe persistent pulmonary

hypertension of the newbom 99

Training, Training in cardiology 302Transcatheter occlusion

Closure of Blalock-Taussig shunts using a new detachable coildevice 383

Transcatheter occlusion of cardiac defects 585Transoesophageal echocardiography

Cardiac involvement in Wegener's granulomatosis 110Value of transoesophageal echocardiography before DC car-

dioversion in patients with atrial fibrillation 306Tricuspid annulus, Radiofrequency catheter ablation of Mahaim

tachycardia by targeting Mahaim potentials at the tricuspidannulus 250

Tricuspid valve replacement, Permanent pacing in patients withtricuspid valve replacements 169

Tuberculous pericarditis, Predictors of constrictive pericarditisafter tuberculous pericarditis 187

Twiddler's syndrome, Twiddler's syndrome in children 190Twins, Effects of type 1 diabetes mellitus on cardiac function 450

Ultrasonics, High wall shear stress proximal to myocardial bridgingand atherosclerosis 462

Unstable angina, Effects of streptokinase in patients presentingwithin 6 hours of prolonged chest pain with ST segment depres-sion 500

USA, Use of the implantable defibrillator 6

Vasoconstrictor peptides, Vasoconstrictor peptides and coldintolerance in patients with stable angina pectoris 25

Venesection, Haemochromatosis presenting as congestive cardiacfailure 73

Ventilatory response, Ventilatory responses to exercise in adultsafter repair of tetralogy of Fallot 445

Ventricular arrhythmia, Increased dispersion of refractoriness inthe absence of QT prolongation in patients with mitral valveprolapse and ventricular arrhythmias 37

Ventricular fibrillation, QT dispersion and components of theQT interval in ischaemia and infarction 32

Ventricular function, Effects of type 1 diabetes mellitus on cardiacfunction 450

Ventricular late potentials, Impaired left ventricular filling inhypertensive left ventricular hypertrophy as a marker of thepresence of an arrhythmogenic substrate 258

Ventricular septal defect, Morphological, haemodynamic, andclinical variables as predictors for management of isolated ven-tricular septal defect 49

Ventricular tachycardiaBenefits of treatment with implantable cardioverter-defibrillators

in patients with stable ventricular tachycardia without cardiacarrest 158

Impaired left ventricular filling in hypertensive left ventricularhypertrophy as a marker of the presence of an arrhythmogenicsubstrate 258

Ventricular tachycardia and exercise related syncope in childrenwith structurally normal hearts 544

Wall stress, High wall shear stress proximal to myocardial bridgingand atherosclerosis 462

Warfarin, Increased markers of thrombogenesis in chronic atrialfibrillation 527

Warm blood, Warm blood cardioplegia 206Wegener's granulomatosis, Cardiac involvement in Wegener's

granulomatosis 110Weight at one year, Birth weight, weight at one year, and left ven-

tricular mass in adult life 363

Young patients, Immediate and long-term clinical outcome ofcoronary angioplasty in patients aged 35 years or less 82

594